BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wang ZJ, An K, Li R, Shen W, Bao MD, Tao JH, Chen JN, Mei SW, Shen HY, Ma YB, Zhao FQ, Wei FZ, Liu Q. Analysis of 72 patients with colorectal high-grade neuroendocrine neoplasms from three Chinese hospitals. World J Gastroenterol 2019; 25(34): 5197-5209 [PMID: 31558867 DOI: 10.3748/wjg.v25.i34.5197]
URL: https://www.wjgnet.com/1007-9327/full/v25/i34/5197.htm
Number Citing Articles
1
Zhen-Zhou Chen, Wang Huang, Zheng-Qiang Wei. Small-cell neuroendocrine carcinoma of the rectum — a rare tumor type with poor prognosis: A case report and review of literatureWorld Journal of Clinical Cases 2020; 8(23): 6095-6102 doi: 10.12998/wjcc.v8.i23.6095
2
Xueliang Ding, Shaobo Tian, Jia Hu, Guobin Wang, Xiangnan Yu, Daan Fu, Ye Yuan, Lin Wang, Zheng Wang. Risk and prognostic nomograms for colorectal neuroendocrine neoplasm with liver metastasis: a population-based studyInternational Journal of Colorectal Disease 2021; 36(9): 1915 doi: 10.1007/s00384-021-03920-y
3
Ming Shi, Zhiyao Fan, Jianwei Xu, Jian Yang, Yongzheng Li, Changhao Gao, Peng Su, Xiao Wang, Hanxiang Zhan. Gastroenteropancreatic neuroendocrine neoplasms G3: Novel insights and unmet needsBiochimica et Biophysica Acta (BBA) - Reviews on Cancer 2021; 1876(2): 188637 doi: 10.1016/j.bbcan.2021.188637
4
Yu-Rui Zhang, Geng-Cheng Hu, Meng-Ke Fan, Hai-Ling Yao, Chen Jiang, Hui-Ying Shi, Rong Lin. Nomograms for Predicting Survival Outcomes in Patients with Neuroendocrine Neoplasms of the Gallbladder Undergoing Primary Tumor Resection: A Population-Based StudyCurrent Oncology 2023; 30(3): 2889 doi: 10.3390/curroncol30030221
5
Guozhi Yu, Shen Liu, Zhijie Wang, Qian Liu, Hongchang Ren, Wenhui Hu. Palliative primary tumor resection may not offer survival benefits for patients with unresectable metastatic colorectal neuroendocrine neoplasms, one multicenter retrospective cohort studyBMC Surgery 2024; 24(1) doi: 10.1186/s12893-024-02380-9
6
Na Li, Yanping Hu, Linguo Wu, Jianduo An. Clinicopathological correlations in 38 cases of gastroenteropancreatic high-grade neuroendocrine neoplasmsFrontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1399079
7
Zhi-Hao Zhao, Yu Huang, Chao Jiang, Guo-Yue Lv, Meng Wang. Comparative prognosis and risk assessment in gallbladder neuroendocrine neoplasms versus adenocarcinomasFrontiers in Endocrinology 2024; 15 doi: 10.3389/fendo.2024.1326112
8
Ioannis A. Ziogas, Panagiotis T. Tasoudis, Luis C. Borbon, Scott K. Sherman, Patrick J. Breheny, Chandrikha Chandrasekharan, Joseph S. Dillon, Andrew M. Bellizzi, James R. Howe. Surgical Management of G3 Gastroenteropancreatic Neuroendocrine Neoplasms: A Systematic Review and Meta-analysisAnnals of Surgical Oncology 2023; 30(1): 148 doi: 10.1245/s10434-022-12643-5
9
Zhen-Zhou Chen, Wang Huang, Zheng-Qiang Wei. Small-cell neuroendocrine carcinoma of the rectum - a rare tumor type with poor prognosis: A case report and review of literatureWorld Journal of Clinical Cases 2020; 8(23): 6089 doi: 10.12998/wjcc.v8.i23.6089
Abstract() |  Core Tip() |  Full Article(HTML)() | Times Cited  (0) | Total Visits (0) | Open
10
Jonathan M. Loree, David Chan, Jennifer Lim, Heather Stuart, Nicolas Fidelman, Jonathan Koea, Jason Posavad, Meredith Cummins, Sarah Doucette, Sten Myrehaug, Boris Naraev, Dale L. Bailey, Andrew Bellizzi, David Laidley, Veronica Boyle, Rachel Goodwin, Jaydi del Rivero, Michael Michael, Janice Pasieka, Simron Singh. Biomarkers to Inform Prognosis and Treatment for Unresectable or Metastatic GEP-NENsJAMA Oncology 2024; 10(12): 1707 doi: 10.1001/jamaoncol.2024.4330
11
Silvia Uccella, Stefano La Rosa, Jasna Metovic, Deborah Marchiori, Jean-Yves Scoazec, Marco Volante, Ozgur Mete, Mauro Papotti. Genomics of High-Grade Neuroendocrine Neoplasms: Well-Differentiated Neuroendocrine Tumor with High-Grade Features (G3 NET) and Neuroendocrine Carcinomas (NEC) of Various Anatomic SitesEndocrine Pathology 2021; 32(1): 192 doi: 10.1007/s12022-020-09660-z
12
Wouhabe Marai Bancheno, Sneha Rao Adidam, Mekdem Abiy Melaku. Metastatic rectal neuroendocrine carcinoma presenting with treatment-refractory immune thrombocytopenia: A case report and literature reviewMedicine 2022; 101(29): e29616 doi: 10.1097/MD.0000000000029616